mergency department thoracotomy (EDT) can be a lifesaving intervention for certain victims of trauma. The Committee on Trauma of the American College of Surgeons has published practice guidelines to facilitate the definition of the appropriate patient population for this intervention. 1 However, the effectiveness of this procedure continues to be an active area of debate. A metaanalysis of EDT reported survival rates ranging from 2.5% to more than 25%. 2 Economic analyses have yielded variable outcomes ranging from costs of $13,674 per survivor to more than $140,000 per survivor. 3, 4 These divergent economic results can be attributed to wide variations in survival rates and different methods used to determine costs.
In economic evaluations of medical technologies, a beneficial outcome (e.g., a saved life, an avoided disease) is not sufficient to warrant the adoption of a new technology. There must be an accounting of the costs required to produce the desired outcomes. Although a successful thoracotomy ideally results in a neurologically intact survivor, it is necessary to account for the costs required to produce that outcome as well as the costs of all suboptimal outcomes.
Unfortunately, previous cost-effectiveness analyses of EDT have ignored provider risks and the hazards posed by occupational injuries. The infrequent and the uncontrolled occurrence of EDT, the rapid and the invasive nature of the procedure, and the potentially increased disease prevalence of human immunodeficiency virus (HIV) and hepatitis in a trauma population all predispose to an increased risk of occupational injury. The seroprevalence of HIV is estimated to be 7.1% among emergency department patients, and may be as high as 14.6% among victims of penetrating trauma. 5 Estimated hepatitis C seroprevalence rates among emergency department patients range from 7.7% to 18%. 6, 7 Although the rate of occupational injury during EDT has not been reported, seroconversion rates are estimated to be as high as 4.3% for HIV and 10% for hepatitis C after an occupational injury. 8, 9 Residents and attending physicians performing EDT are at risk for the development of HIV, hepatitis C, and the clinical sequelae of AIDS and chronic hepatitis C. A thorough consideration of the efficacy and benefits of EDT must account for these attendant hazards. Ideally, a prospective study of occupational exposures during EDT could provide insight into provider risk and the additional economic costs associated with the procedure. However, the acquisition of sufficient, actual cost information would require a multicenter collaboration with many years of follow-up evaluation. In the absence of such an ambitious effort, an economic model based on standard assumptions from the literature could provide the best estimate of infectious risk and the additional costs associated with the procedure. The purpose of this analysis was to estimate the economic costs of HIV and hepatitis exposure associated with percutaneous injury to providers who perform EDT.
MATERIALS AND METHODS
To estimate the occupational hazards associated with EDT, a decision tree of occupational exposure associated with EDT was created. It was assumed that all providers with an occupational injury undergo initial counseling and evaluation. The risk and progression of HIV and hepatitis C were modeled as independent events. Postexposure testing, therapy, and follow-up evaluation were based on Centers for Disease Control (CDC) recommendations.
10

HIV Model
The point seroprevalence of HIV in emergency department patients varies by the population studied. One study of emergency department patients in an inner-city level 1 trauma center detected HIV in 9 of 126 critically ill patients over a 6-week period. If these data are further classified according to patients with penetrating trauma, the point seroprevalence increases to 14.6%. 5 A separate study of HIV infection in a trauma center treating primarily rural, blunt trauma victims determined HIV seroprevalence to be 1.67%.
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The decision tree for occupational exposure to HIV assigns individuals to one of three health states (Fig. 1) . All source patients are screened for HIV antibody, with confirmatory testing following as needed. 10 Once a provider sustains an occupational exposure, the decision tree determines the probability of HIV in the source patient, followed by the probability of seroconversion. Providers exposed to an HIVnegative source complete a 5-day course of HIV postexposure prophylaxis (PEP), which corresponds to the longest waiting time for the results of HIV source testing in the authors' institution. For this analysis, the PEP regimen consists of zidovudine (Retrovir, ZDV, AZT), 300 mg twice daily, and lamivudine (Epivir, 3TC), 150 mg twice daily. Individuals exposed to an HIV-negative source also undergo a baseline complete blood count as well as renal and hepatic function tests. 10 The CDC estimates the probability of HIV seroconversion after an occupational exposure to be 0.3%, although a deep injury may be associated with a seroconversion rate as high as 4.5%. 8, 10 Postexposure prophylaxis is estimated to decrease the probability of seroconversion by 81%. 10 For individuals expected to seroconvert, the decision model assumes a seroconversion rate of 50% at 3 months and the remaining 50% at 6 months. The decision tree assumes that all providers exposed to an HIV-positive source complete 1 month of PEP. These individuals also are expected to have a complete blood count along with renal and hepatic function tests at baseline and at 2 weeks as well as HIV testing at baseline, at 6 weeks, at 3 months, and at 6 months, with confirmatory testing as needed.
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Hepatitis C Model
Several studies have estimated the prevalence of hepatitis C infection in emergency department patients. An analysis of all emergency department patients in an inner-city level 1 trauma center determined a hepatitis C seroprevalence of 18%. 7 Other studies have refined this estimate for trauma patients exclusively. A study of 132 emergency department The Journal of TRAUMA Injury, Infection, and Critical Care patients with a life-threatening injury identified 16 individuals (12.1%) with hepatitis C. 12 A similar study of only trauma patients presenting to a level 1 trauma center estimated point seroprevalence to be 7.7%. Among patients with penetrating trauma, the prevalence increased to 11%. 6 The decision tree for occupational exposure to hepatitis C assigns exposed individuals to one of six health states (Fig.  2 ). All source individuals undergo initial anti-hepatitis C antibody testing and confirmatory testing as needed. All exposed individuals undergo anti-hepatitis C and alanine aminotransferase testing at baseline and at 6 months, as well as anti-HCV confirmatory testing as needed. Interferon treatment is currently not recommended for PEP. 10 In the decision tree, the majority of providers exposed to hepatitis C will remain seronegative. If a provider is exposed to hepatitis C, the seroconversion rate varies between 1.8% and 10%. 9, 10 For individuals who seroconvert, the decision tree assumes that clinically apparent acute hepatitis will develop in 30% of patients. 13 The decision tree also estimates a 15% probability that acute hepatitis C will completely resolve. In the remaining 85%, chronic hepatitis C will develop, and these patients will be at risk for the long-term complications of cirrhosis, liver failure, and hepatocellular carcinoma. 14 
Hepatitis B Model
The decision tree assumes that all providers are immunized and have active immunity against hepatitis B. The CDC guidelines currently do not recommend exposure or source testing for exposed patients who have completed the hepatitis B immunization series. 10 However, the decision tree conforms to the practices of the authors' institution. Source patients are tested for hepatitis B surface antigen, and exposed patients who have completed hepatitis B immunization are tested for antibody to hepatitis B surface antigen.
Costs
A health care system perspective is used for this analysis. This perspective considers the direct medical costs associated with the intervention. Indirect medical costs and productivity losses are not included in the analysis. All costs are reported in year-2000 dollars.
The short-term direct medical costs of counseling and laboratory testing are based on hospital charges at the Boston Medical Center during the year 2000 ( Table 1 ). The cost of HIV PEP is derived from the 2000 Drug Topics Redbook. 15 The lifetime medical costs of HIV are derived from a published standard in the literature, 16 and the lifetime medical costs of chronic hepatitis C are derived from a Monte Carlo simulation of 12 months of interferon alpha therapy. 17 All lifetime medical costs are adjusted to year-2000 dollars using the medical care component of the consumer price index.
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Analysis
The decision tree for HIV and hepatitis C model the occupational exposures associated with EDT. The short-and long-term medical costs associated with occupational injury are calculated for the discrete health states. The expected cost of each health state is calculated by multiplying the probability of occurrence associated with each health state by the medical cost. The expected costs for each health state then are summed together to determine an aggregate cost for each decision tree. All calculations are performed using Microsoft Excel 1997 (Microsoft Corporation, Redmond, WA).
The base case prevalences of HIV (7.1%) and hepatitis C (18%) are based on the seroprevalence estimates of emer- 
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Volume 56 • Number 4gency department patients in an inner-city level 1 trauma center. 5, 7 The probability of seroconversion to HIV (0.3%) and hepatitis C (1.8%) are based on CDC estimates. The effect of HIV PEP prophylaxis assumes an 81% decrease in the probability of seroconversion. 10 Two additional models were created to test the effect of varying the exposure rate and the disease prevalence rate on cost estimates. A penetrating trauma model used revised prevalence estimates of HIV (14.6%) and hepatitis C (11%) based on the estimated prevalence of disease in emergency department patients sustaining penetrating trauma. 5, 6 The effect produced by increasing the probability of HIV (4.5%) and hepatitis C (10%) seroconversion to the highest levels reported in the literature so they reflect the possibility of a more invasive exposure associated with hollow needle punctures and lacerations from scalpel blades and fractured ribs also was examined. Table 2 presents the probabilities and costs associated with the three health states of the HIV occupational exposure decision tree. Health state 3, an occupational exposure in an HIV-negative patient, is associated with the largest probability of occurrence. Although the costs associated with seroconversion are significant, the low probability associated with the first health state results in a relatively small contribution toward the overall cost associated with an occupational exposure.
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RESULTS
The highest probability in the hepatitis C decision tree is associated with individuals exposed to hepatitis C-negative patients (Table 3) . Although the short-term costs associated with the first health state are comparatively less than those for other health states, the higher probability of occurrence The Journal of TRAUMA Injury, Infection, and Critical Care makes this a major contributor to costs. In contrast, the significant short-and long-term costs associated with chronic hepatitis C in health states 3 and 5 are offset by the relatively low probability of occurrence. Table 4 presents the expected cost associated with an EDT occupational exposure. The initial evaluation, including initial counseling and confirmation of hepatitis B immunity, is responsible for most of the short-term costs from any occupational exposure. The low probabilities associated with HIV and hepatitis C seroconversion lead to a small impact on long-term costs. The total additional cost is $1,377 per thoracotomy associated with an exposure.
Varying the prevalence of HIV and hepatitis C to reflect the characteristics of a patient population with penetrating trauma increases the population prevalence of HIV and decreases the population prevalence of hepatitis C. This results in a minimal economic difference from the base case, with an additional cost of $1,383 per EDT associated with an exposure. However, changing the rates of disease seroconversion to the maximum probabilities found in the literature increases the probability of both HIV and hepatitis C seroconversion and increases the overall additional costs to approximately $1,900 per EDT with occupational exposure.
DISCUSSION
Emergency department thoracotomy can be associated with significant occupational hazards to medical providers. Given standard estimates of disease prevalence and seroconversion, an EDT-related occupational exposure would be expected to add more than $1,000 to health care costs. Most of these costs result from the initial evaluation and baseline testing of all exposed providers. The impact of the long-term costs associated with HIV and hepatitis C seroconversion is blunted by the relatively low probability that these events will occur. The results of this analysis should not be interpreted as a measurement of individual provider risk. This analysis quantifies occupational exposure costs and provides an estimate of the average additional costs associated with an EDTrelated exposure.
The current analysis used hospital charges as a surrogate for medical costs. Charges and medical costs are not equivalent. 19 However, the hospital charges reflect the magnitude of the economic consequences associated with EDT occupational exposure. The study model does not address the emotional toll and potential lost income associated with occupational exposures. Although it is possible to assign value for the income lost by providers driven from the practice of medicine, it is difficult to quantify the emotional toll of waiting for source testing results and future provider testing to rule out disease seroconversion.
After an occupational injury, some exposed individuals may be more focused on the risks associated with HIV. The study data indicate that the more appropriate area of concern is the possible development of hepatitis C and chronic hepatitis. The overall higher probability of hepatitis C seroconversion and the lack of hepatitis C PEP causes the study model to yield a consistently higher probability of hepatitis C seroconversion, as compared with HIV.
The study model also may provide inappropriate comfort regarding other infectious diseases. The decision tree assumes that all emergency department and surgical providers possess active immunity against hepatitis B. This may be an overly optimistic and hazardous assumption. A study of antibody titers to hepatitis B surface antigen among 943 vaccinated emergency physicians found borderline titers in 5% and nonreactive titers in 14%. 20 Inadequate immunity is compounded by the higher rates of hepatitis B seroconversion after an occupational injury. 10 Additional modeling of EDT occupational exposures could take into account variable immunity against hepatitis B.
The magnitude of the economic impact of EDT occupational exposures depends on the number of EDTs performed and the rate of occupational exposure. An observational study of percutaneous injury during surgical procedures found a 5% rate of injury for surgical procedures associated with abdominal trauma and a 3% rate of percutaneous injury for surgical procedures in the setting of nonabdominal trauma. 21 Coronary artery bypass grafting, a procedure analogous to EDT, was associated with a 9% rate of percutaneous injury. 21 If EDT is performed less frequently and the rate of occupational exposure is similarly low, then the potential economic burden on a health care system may be minimal. However, the potential impact at the level of the exposed individual could be catastrophic.
The study model may underestimate the possibility of provider seroconversion to HIV. The rapidly invasive and urgent nature of EDT may predispose to occupational injuries associated with a higher rate of seroconversion than reported 
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Volume 56 • Number 4in the literature. At-risk providers may refuse HIV PEP or may be noncompliant with therapy. 8, 22 The study model also assumes that all trauma patients can be screened for HIV. If this is not possible, exposed providers may be required to complete a 1-month course of PEP, thereby increasing costs. Similarly, the introduction of rapid bedside tests for HIV source testing could eliminate the PEP medication costs and the emotional toll associated with waiting for results in an HIV-negative source patient. 23 Further studies on the rate of EDT occupational exposure and the timing and compliance with PEP are needed for more refined and accurate models.
CONCLUSIONS
To the authors' knowledge, this is the first attempt to quantify the occupational hazards associated with EDT. The risks of exposure to HIV and hepatitis C in particular are significant at both the medical and economic levels. These risks and their potential economic burden should be considered when EDT is performed for teaching purposes in nearly futile cases. Future analyses of EDT should include an assessment of these factors in reports on the cost effectiveness of this procedure, especially in situations for which the survival rate is extremely low.
